Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Decellularized Versus Standard Pulmonary Allografts in the Ross Procedure: Propensity-Matched Analysis

Francisco D.A. da Costa, Jonathan R.G. Etnel, Efstratios I. Charitos, Hans Hinrich Sievers, Ulrich Stierle, Daniele Fornazari, Johanna J.M. Takkenberg, Ad J.J.C. Bogers, M. Mostafa Mokhles*

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Background: It is hypothesized that decellularization of allografts used for right ventricular outflow tract reconstruction may result in decreased valve deterioration. This study compared the durability of fresh decellularized pulmonary allografts with standard cryopreserved pulmonary allografts in patients undergoing the Ross procedure. Methods: The Ross procedure was performed in 144 patients with decellularized allografts (DA) from 2005 to 2014 and in 619 with standard cryopreserved allografts (SCA) from 1990 to 2014. Propensity score matching was used to compare early and midterm clinical outcome and echocardiographic allograft function over time between the two groups. Results: We matched 94 DA patients (79.3% male; median age, 34.0 years; mean follow-up, 2.4 ± 1.9 years) to 94 SCA patients (78.3% male; median age, 35.0 years; mean follow-up, 9.4 ± 4.2 years). There were no significant differences in baseline characteristics after matching. The matched DA vs SCA groups, respectively, were comparable in actuarial 5-year freedom from allograft dysfunction (85.6% [95% confidence interval {CI}, 53.9% to 96.2%] vs 93.3% [95% CI, 85.7% to 96.9%], p = 0.892), freedom from allograft reintervention (98.8% [95% CI, 91.7% to 99.8%] vs 95.5% [95% CI, 88.5% to 98.3%], p = 0.383), survival (95.3% [95% CI, 87.8% to 98.2%] vs 97.7% [95% CI, 91.3% to 99.4%], p = 0.323), and event-free survival (83.5% [95% CI, 70.6% to 91.1%] vs 84.5% [95% CI, 75.2% to 90.5%], p = 0.515). Longitudinal echocardiographic analyses showed a similarly modest increase in allograft gradient and regurgitation grades over time in both groups, although direct statistical comparison was not possible. Conclusions: Up to 5 years of follow-up, DA and SCA used for right ventricular outflow tract reconstruction in the Ross procedure are associated with comparably excellent clinical and hemodynamic outcome. Longer follow-up and dedicated echocardiographic studies will shed light on the long-term performance of DAs.

OriginalspracheEnglisch
ZeitschriftAnnals of Thoracic Surgery
Jahrgang105
Ausgabenummer4
Seiten (von - bis)1205-1213
Seitenumfang9
ISSN0003-4975
DOIs
PublikationsstatusVeröffentlicht - 04.2018

Fördermittel

Jonathan R.G. Etnel is funded by the Dutch Heart Foundation (2013T093). M. Mostafa Mokhles is funded by a VENI grant of the Netherlands Organisation for Scientific Research (NWO 916.160.87) and an Erasmus University Rotterdam n EUR Fellowship grant (UB/HP/SvR/264.133).

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Decellularized Versus Standard Pulmonary Allografts in the Ross Procedure: Propensity-Matched Analysis“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren